Y, L., D, Y., Y, W., Z, L., & C, Z. (2018). Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency. Dove Medical Press.
Chicago Style (17th ed.) CitationY, Li, Yang D, Wang Y, Li Z, and Zhu C. Co-delivery Doxorubicin and Silybin for Anti-hepatoma via Enhanced Oral Hepatic-targeted Efficiency. Dove Medical Press, 2018.
MLA (8th ed.) CitationY, Li, et al. Co-delivery Doxorubicin and Silybin for Anti-hepatoma via Enhanced Oral Hepatic-targeted Efficiency. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.